F. de Marinis

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Vall d'Hebron Hospital Universitari(Current)

European Institute of Oncology

Vall d'Hebron Institute of Oncology

F. de Marinis is an author at Vall d'Hebron Hospital Universitari specializing in non-small cell lung cancer treatment, non-small cell lung cancer therapy, and pharmacology.

Publications per year

2022–2022

Publications

LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation

P.A. Jänne, E.F. Smit, F. de Marinis et al. · Immuno-Oncology Technology · 2022 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

1008P Resistance mechanisms to lorlatinib or crizotinib in treatment-naive patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC)

E. Felip, J-F. Martini, J. Mazieres et al. · Annals of Oncology · 2022 · 10 citations

Medicine, Oncology, Pharmacology +16

1–2 of 2